当前位置:首页 - 行情中心 - 誉衡药业(002437) - 财务分析

誉衡药业

(002437)

  

流通市值:61.36亿  总市值:65.58亿
流通股本:21.01亿   总股本:22.46亿

誉衡药业(002437)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.62亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益195829.37万元,未分配利润-62049.53万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产287865.10万元,负债92035.73万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入551,255,672.122,440,732,030.171,857,506,712.571,221,310,646.18
营业总成本493,551,043.762,218,794,751.251,686,482,833.111,108,279,372.88
营业利润69,069,634.07284,852,984.63222,300,997.03153,266,084.38
利润总额68,950,223.62283,692,120.46222,057,887153,069,234.94
净利润61,931,584.62242,540,034.93191,786,315.95131,525,778.29
其他综合收益-40,526.17476,998.7-388,301225,425.69
综合收益总额61,891,058.45243,017,033.63191,398,014.95131,751,203.98
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计946,591,300.71877,194,205.18870,427,011.96874,135,638.92
非流动资产合计1,932,059,699.731,947,918,407.461,956,651,982.421,966,037,524.82
资产总计2,878,651,000.442,825,112,612.642,827,078,994.382,840,173,163.74
流动负债合计891,911,303.84823,033,579.93871,852,980.11837,729,658.06
非流动负债合计28,446,043.5229,226,752.7740,688,194.5761,410,125.67
负债合计920,357,347.36852,260,332.7912,541,174.68899,139,783.73
归属于母公司股东权益合计1,934,459,343.331,950,697,287.551,893,916,132.241,921,972,954.46
股东权益合计1,958,293,653.081,972,852,279.941,914,537,819.71,941,033,380.01
负债和股东权益合计2,878,651,000.442,825,112,612.642,827,078,994.382,840,173,163.74
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计657,540,118.812,903,133,022.932,184,252,323.731,443,742,278.23
经营活动现金流出小计551,065,624.662,492,197,219.821,883,749,821.111,241,850,331.22
经营活动产生的现金流量净额106,474,494.15410,935,803.11300,502,502.62201,891,947.01
投资活动现金流入小计263,561,086.0436,696,852.831,412,568.9722,142,400
投资活动现金流出小计376,511,825.9695,560,805.1436,264,769.4523,987,033.63
投资活动产生的现金流量净额-112,950,739.92-58,863,952.34-4,852,200.48-1,844,633.63
筹资活动现金流入小计70,000,000218,213,750218,213,750205,488,750
筹资活动现金流出小计82,605,612.77801,456,448.33755,655,263.66683,273,443.31
筹资活动产生的现金流量净额-12,605,612.77-583,242,698.33-537,441,513.66-477,784,693.31
汇率变动对现金及现金等价物的影响-90,972.85939,419.49-674,429.25389,995.57
现金及现金等价物净增加额-19,172,831.39-230,231,428.07-242,465,640.77-277,347,384.36
期末现金及现金等价物余额461,608,103.49480,772,690.45468,538,477.75433,656,734.16
TOP↑